Tacrolimus in Pregnancy

Starting soon

Conditions studied: Unbound Tacrolimus in Pregnant Uterus Transplant Recipients, Whole Blood Tacrolimus in Pregnant Uterus Transplant Recipients

In brief

To create a formula that adjusts tacrolimus blood levels. This is needed because pregnant patients have higher levels of unbound tacrolimus. The adjusted formula will give a more accurate measure of the active drug in pregnant uterus transplant patients.

Key facts

Study ID

NCT07422012

Run by

Baylor Research Institute

People needed

55

Starts

2026-05-31

Expected to finish

2028-03-01

Last updated by the study team

2026-04-28

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Uterus transplant recipient
• 18 to 50 years of age
• receiving tacrolimus for immunosuppression.

You may not qualify if…

• Individuals who have not had a uterine transplant
• individuals over 50 years old

Where it is running

• Baylor University Center of Dallas — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.